Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Dr. Helmut Bjerk Dr. Clemens Rufer Dr. Eberhard Schroder Dr. Dr. Erich Gerhardt Dr. Wolfgang Felix Losert Dr. Olaf Loge And Dr. Ekkehard Schillinger Dr. Hanns Ahrens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2150279Aexternal-prioritypatent/DE2150279C2/en
Application filed by Schering AGfiledCriticalSchering AG
Application grantedgrantedCritical
Publication of AU4735672ApublicationCriticalpatent/AU4735672A/en
Publication of AU483774B2publicationCriticalpatent/AU483774B2/en
AU47356/72A1971-10-051972-10-04Sulphamoyl-pyrimidines containing an asymmetric 1 carbon atom and having a blood sugar lowering activity
ExpiredAU483774B2
(en)